CYPHERPUNK TECHNOLOGIES INC. Capital Expenditures
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Capital Expenditures of $100.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2021-03-12
- CYPHERPUNK TECHNOLOGIES INC. payments to acquire property, plant, and equipment for the quarter ending 2019-12-31 was $0.00.
- CYPHERPUNK TECHNOLOGIES INC. payments to acquire property, plant, and equipment for the quarter ending 2019-09-30 was $0.00.
- CYPHERPUNK TECHNOLOGIES INC. payments to acquire property, plant, and equipment for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. payments to acquire property, plant, and equipment for the quarter ending 2017-09-30 was -$2.00K.
- CYPHERPUNK TECHNOLOGIES INC. payments to acquire property, plant, and equipment for fiscal 2019 was $100.00K.
- CYPHERPUNK TECHNOLOGIES INC. payments to acquire property, plant, and equipment for fiscal 2017 was $64.00K, a 55.56% decline from fiscal 2016.
- CYPHERPUNK TECHNOLOGIES INC. payments to acquire property, plant, and equipment for fiscal 2016 was $144.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $0.00 derived: sum of 2 quarters · filed 2021-03-12 | $100.00K 10-K · filed 2021-03-12 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $100.00K 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $100.00K 10-Q · filed 2020-08-13 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$2.00K derived: sum of 2 quarters · filed 2019-04-01 | -$1.00K derived: sum of 3 quarters · filed 2019-04-01 | $64.00K 10-K · filed 2019-04-01 |
| 2017-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$1.00K derived: sum of 2 quarters · filed 2018-11-09 | $64.00K 10-Q · filed 2018-11-09 | $72.00K derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | $1.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-08 | $66.00K 10-Q · filed 2018-08-08 | $74.00K derived: sum of 3 quarters · filed 2018-08-08 | $74.00K derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | $65.00K 10-Q/A · filed 2018-08-08 | $73.00K derived: sum of 2 quarters · filed 2018-08-08 | $73.00K derived: sum of 3 quarters · filed 2018-08-08 | $179.00K derived: sum of 4 quarters · filed 2018-08-08 |
| 2016-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $8.00K derived: sum of 2 quarters · filed 2018-02-23 | $114.00K derived: sum of 3 quarters · filed 2018-02-23 | $144.00K 10-K · filed 2018-02-23 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $106.00K derived: sum of 2 quarters · filed 2017-11-13 | $136.00K 10-Q · filed 2017-11-13 | |
| 2016-06-30 | $106.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $136.00K 10-Q · filed 2017-08-11 | ||
| 2016-03-31 | $30.00K 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |